Table 4

RECIST best response summary

Best RECIST response
Confirmed CR1 (6)
Confirmed PR3 (19)
Unconfirmed PR1 (6)
Clinical benefit (stable disease for 6 months+)2 (12)
Progression7 (44)
Not assessed*2 (12)
  • N (%) reported.

  • *Two patients did not have tumor measurements available and were not assessable due to stopping protocol therapy due to adverse events before first scan (n=1) or death before first assessment time point (n=1).

  • CR, complete response; PR, partial response.